
- Telehealth Visits
- Insurance plan information


Rita Nieu, OD, MS
She | Her | HersOptometry- Telehealth Visits
- Insurance plan information




Rita Nieu, OD, MS
She | Her | HersOptometry- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Rita Nieu is an optometrist who provides comprehensive eye care for patients of all ages. Her diverse experience includes diagnosing, treating and managing cataracts, glaucoma, retinal tears and detachments, diabetic retinopathy, macular degeneration and other ocular conditions. She also prescribes glasses and contact lenses to address near- and farsightedness, astigmatism and other common vision problems.
Nieu takes an integrative approach to patient wellness, seeking to treat the whole person rather than a single condition. She also has a special interest in working with populations whose health care access has been historically limited.
Nieu earned a combined doctor of optometry and master's degree in vision sciences at the State University of New York College of Optometry, where she conducted research on slowing down the progression of myopia (nearsightedness) in children. She completed a residency in ocular disease, low vision and traumatic brain injury at the West Haven Veterans Affairs Medical Center.
Education & training
Residency
- Ocular Disease and Low Vision, VA Connecticut Healthcare System West Haven GME
Degree
- OD, SUNY College of Optometry
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224267%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224267%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.